MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$49.82 0.38 (0.77%)
Open Price: 49.33
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients